title: Motor protein function in skeletal abdominal muscle of cachectic cancer patients.
abstract: Cachexia presents with ongoing muscle wasting, altering quality of life in cancer patients. Cachexia is a limiting prognostic factor for patient survival and health care costs. Although animal models and human trials have shown mechanisms of motorprotein proteolysis, not much is known about intrinsic changes of muscle functionality in cancer patients suffering from muscle cachexia, and deeper insights into cachexia pathology in humans are needed. To address this question, rectus abdominis muscle samples were collected from several surgical control, non-cachectic and cachectic cancer patients and processed for skinned fibre biomechanics, molecular in vitro motility assays, myosin isoform protein compositions and quantitative ubiquitin polymer protein analysis. In pre-cachectic and cachectic cancer patient samples, maximum force was significantly compromised compared with controls, but showed an unexpected increase in myofibrillar Ca(2+) sensitivity consistent with a shift from slow to fast myosin isoform expression seen in SDS-PAGE analysis and in vitro motility assays. Force deficit was specific for 'cancer', but not linked to presence of cachexia. Interestingly, quantitative ubiquitin immunoassays revealed no major changes in static ubiquitin polymer protein profiles, whether cachexia was present or not and were shown to mirror profiles in control patients. Our study on muscle function in cachectic patients shows that abdominal wall skeletal muscle in cancer cachexia shows signs of weakness that can be partially attributed to intrinsic changes to contractile motorprotein function. On protein levels, static ubiquitin polymeric distributions were unaltered, pointing towards evenly up-regulated ubiquitin protein turnover with respect to ubiquitin conjugation, proteasome degradation and de-ubiquitination.
authors.affiliation: Institute of Physiology and Pathophysiology, Ruprecht-Karls-University, Heidelberg, Germany.
authors.forename: Sultan
authors.initials: S
authors.lastname: Taskin
authors.forename: Vera Isabell
authors.initials: VI
authors.lastname: Stumpf
authors.forename: Jeannine
authors.initials: J
authors.lastname: Bachmann
authors.forename: Cornelia
authors.initials: C
authors.lastname: Weber
authors.forename: Marc Eric
authors.initials: ME
authors.lastname: Martignoni
authors.forename: Oliver
authors.initials: O
authors.lastname: Friedrich
mesh_terms: D000009:Abdominal Muscles / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002100:Cachexia / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D002118:Calcium / Q000502:physiology; D003110:Colonic Neoplasms / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction; D009218:Myosins / Q000502:physiology*; D010190:Pancreatic Neoplasms / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D020033:Protein Isoforms / Q000378:metabolism; D059010:Single-Cell Analysis; D025801:Ubiquitin / Q000378:metabolism
chemical_list: D020033:Protein Isoforms; D025801:Ubiquitin; D009218:Myosins; D002118:Calcium
keywords: cancer; contractility; motility assay; muscle cachexia; myosin isoforms